Media
Subscribe
Contact
IPO

Search

- ENG
- SWE

ENG
SWE

About us
- About us
  
  Company History
  
  Company strategy
  
  Career
  
  Licensed partners
  
  Board of directors
  
  Management team
Our science
- Our science
  
  About Gerd
  
  Patient Story - Life with GERD
  
  Patient Story - Everyday life with GERD
  
  Linaprazan glurate
  
  PPIs versus P-CABs
  
  Development strategy
  
  Clinical development
Governance
- Governance
  
  Corporate Governance Reports
  
  General Meetings
  
  2024
  
  2023
  
  2022
  
  Board of directors
  
  The work of the board
  
  Board committees
  
  Management
  
  Founders & Senior Advisors
  
  Nomination Committee
  
  Nomination committee instructions
  
  Remuneration
  
  Guidelines for remuneration
  
  Auditing
  
  Articles of Association
  
  Internal control
Investors
- Investors
  
  The Share
  
  Ownership structure
  
  Dividend policy
  
  Analyst coverage
  
  Financial Reports
  
  Annual Reports
  
  Interim Reports
  
  Press releases
  
  Calendar
  
  Presentations
Media
Subscribe
Contact
IPO

Home /
Media /
News /
Read the full analysis of Cinclus Pharma in the article by Börsveckan.

Read the full analysis of Cinclus Pharma in the article by Börsveckan.

15 Jul 2024

cinclus pharma male doctor consulting woman

Read the full analysis (in Swedish) of Cinclus Pharma in the article by Börsveckan.

Back

Cinclus Pharma Holding AB (publ)
Kungsbron 1
Level 3, Elevator G
111 22 Stockholm
SWEDEN

Phone: +46 8-133310
E-mail: info@cincluspharma.com

Navigate

About us
Our science

Join our network

© CINCLUS PHARMA 2024Privacy policy